Home Medical Devices asia-pacific-interventional-cardiology-peripheral-vascular-devices-market

Medical Devices

Image

Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Published Report
  • Mar 2022
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 326
  • No of Figures: 48

Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market, By Product (Angioplasty Balloons, Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices & Others and Accessories), Type (Conventional and Advanced), Procedure (Iliac Intervention, Femoropopliteal Interventions, Tibial (Below-The-Knee) Interventions, Peripheral Angioplasty, Arterial Thrombectomy and Peripheral Atherectomy), Indication (Peripheral Arterial Disease and Coronary Intervention), Age Group (Geriatric, Adults and Paediatric) End User (Hospitals, Ambulatory Surgery Centers, Nursing Facilities, Clinics and Others), Distribution Channel (Direct Tender, Third Party Distributors and Others) Industry Trends and Forecast to 2029.

Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market

Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Analysis and Insights  

Chronic diseases and conditions are on the rise globally. The coronary heart disease (CHD) is largely preventable, as many of its risk factors are modifiable. These include tobacco smoking, biomedical risk factors, such as high blood pressure and high blood cholesterol, insufficient physical activity, poor diet and nutrition, and overweight and obesity. The financial burden for the treatment of coronary artery disease and vascular disease arises due to hospitalizations, treatments, revascularization procedures, clinic visits, emergency visits, and prescribed drug treatments.

Asia-Pacific Interventional Cardiology

The drivers responsible for the growth of the Asia-Pacific interventional cardiology and peripheral vascular devices market are the increased prevalence of coronary artery diseases, ischemic heart disease and vascular disease, surge in awareness about the timely treatment and use of the devices, technological advancements in the cardiology and peripheral vascular devices, increased interest towards non-invasive surgery and favorable reimbursement policies. However, factors that are expected to restrain the market growth are rise in the cost of the devices, risks observed while using the devices, rise in product recall, and availability of alternate treatments.

The interventional cardiology and peripheral vascular devices is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyses that the interventional cardiology and peripheral vascular devices market will grow at a CAGR of 8.4% during the forecast period of 2022 to 2029.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Pricing in USD

Segments Covered

By Product (Angioplasty Balloons, Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (Ivc) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Others & Accessories), Type (Conventional and Advanced), Procedure (Iliac Intervention, Femoropopliteal Interventions, Tibial (Below-The-Knee) Interventions, Peripheral Angioplasty, Arterial Thrombectomy and Peripheral Atherectomy), Indication (Peripheral Arterial Disease and Coronary Intervention.), Age Group (Geriatric, Adults and Paediatric ) End User (Hospitals, Ambulatory Surgery Centers, Nursing Facilities, Clinics and Others.), Distribution Channel (Direct Tender, Third Party Distributors and Others)

Countries Covered

China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific

Market Players Covered

Medtronic, BD., Cordis., Abbott., Boston Scientific Corporation, AngioDynamics., SMT, Edwards Lifesciences Corporation., Biosensors International Group, Ltd., W. L. Gore & Associates, Inc., Teleflex Incorporated., OrbusNeich Medical Company Limited, Merit Medical Systems., Terumo Medical Corporation, B. Braun Melsungen AG, MicroPort Scientific Corporation, Lepu Medical Technology(Beijing)Co.,Ltd and Koninklijke Philips N.V.

Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Dynamics

Drivers

  • The Rise in Prevalence of Chronic Diseases, such as Coronary Artery Disease, Ischemic Heart Disease and Vascular Diseases

Chronic diseases and conditions are on the rise globally. The coronary heart disease (CHD) is largely preventable, as many of its risk factors are modifiable. These include tobacco smoking, biomedical risk factors, such as high blood pressure and high blood cholesterol, insufficient physical activity, poor diet and nutrition, and overweight and obesity. The financial burden of coronary artery disease and vascular disease arises from hospitalizations, treatments, revascularization procedures, clinic visits, emergency visits, and prescribed drug treatments, thereby propelling the growth of the market.

  • Awareness Among the Population about the Treatment and Use of the Devices

Coronary heart disease is the leading cause of death among women. The knowledge about heart and vascular disease can impart a healthy lifestyle. The adequate awareness about symptoms and their risk factors may help reduce the population's exposure to modifiable risk factors and thereby contribute to prevention and control strategies. Awareness about the symptoms of cardiovascular and vascular diseases would result in timely treatment.

Also, the favourable reimbursement policies in these countries is expected to drive the growth of market.

Furthermore, Increase in strategic initiatives by key players, advancement in medical technology, recent advancements in cardiology and peripheral vascular devices, rising initiatives by public and private organizations to spread awareness and growing government funding are the factors that will expand the gastric cancer treatment market.

Asia-Pacific Interventional Cardiology

Opportunities

  • Growing Geriatric Population

Moreover, the world’s geriatric population is increasing at a rapid rate. Elderly people have become an increasingly prevalent population of various cardiovascular diseases, which are considered as the most distributed cause of death worldwide will boost new opportunities for the market's growth rate.

Also, the increasing drug approvals will provide beneficial opportunities for the interventional cardiology and peripheral vascular devices market in the forecast period of 2022-2029. Also, the partnership and agreement by major players will escalate the growth rate of the interventional cardiology and peripheral vascular devices in the future.

Restraints/Challenges Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market

However, the rise in cost of catheters and balloon angioplasty devices is due to technological development and increased demand for interventional cardiology and peripheral vascular devices by cardiologists in hospitals, clinics, nursing facilities, and ambulatory surgical centres. Due to high research and development costs, the cost of clinical trials of the cardiology and peripheral vascular devices and market factors, a unique cardiology device will carry a premium price. Therefore, the present high cost is expected to show a descending trend in the future

This interventional cardiology and peripheral vascular devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on interventional cardiology and peripheral vascular devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post COVID-19 Impact on Interventional Cardiology and Peripheral Vascular Devices Market

The COVID-19 has negatively affected the interventional cardiology and peripheral vascular devices market. Lockdowns and isolation during pandemics complicate the disease management and medication adherence. The lack of access to health-care facilities for routine treatment and medication administration will further affect the market. Social isolation increases stress, despair, and social support, all of which may cause a reduction in anticonvulsant medication adherence during the pandemic.

Recent Development

  • In September 13, 2021, Medtronic announced that the company collaborated with Mpirik who are known to provide a suite of cloud based automated patient screening and care pathway for cardiovascular diseases. This collaboration helps company to address disparities in care associated with prevention of sudden cardiac arrest with their advanced artificial intelligence platform, thereby aiding company to further improve their leadership in market

Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Scope

Asia-Pacific interventional cardiology and peripheral vascular devices market is categorized into seven notable segments, which are based on product, type, procedure, indication, age group, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product

  • Angioplasty Balloons
  • Stent
  • Catheters
  • Endovascular Aneurysm Repair Stent Grafts
  • Inferior Vena Cava (IVC) Filters
  • Plaque Modification Devices
  • Hemodynamic Flow Alteration Devices
  • Others & Accessories

On the basis of product, the Asia-Pacific interventional cardiology and peripheral vascular devices market is segmented into angioplasty balloons, stent, catheters, endovascular aneurysm repair stent grafts, inferior vena cava (IVC) filters, plaque modification devices, others & accessories and hemodynamic flow alteration devices.

Type

  • Conventional
  • Advanced

On the basis of type, the Asia-Pacific interventional cardiology and peripheral vascular devices market is segmented into conventional and advanced.

Procedure

  • Iliac Intervention
  • Femoropopliteal Interventions
  • Tibial (Below-The-Knee) Interventions
  • Peripheral Angioplasty
  • Arterial Thrombectomy
  • Peripheral Atherectomy

On the basis of procedure, the Asia-Pacific interventional cardiology and peripheral vascular devices market is segmented into iliac intervention, femoropopliteal interventions, tibial (below-the-knee) interventions, peripheral angioplasty, arterial thrombectomy, and peripheral atherectomy.

Indication

  • Peripheral Arterial Disease
  • Coronary Intervention

On the basis of indication, the Asia-Pacific interventional cardiology and peripheral vascular devices market is segmented into peripheral arterial disease and coronary intervention.

Age Group

  • Geriatric
  • Adults
  • Pediatric

On the basis of age group, the Asia-Pacific interventional cardiology and peripheral vascular devices market is segmented into geriatric, adults, and paediatric.

End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Nursing Facilities
  • Clinics
  • Others

On the basis of end user, the Asia-Pacific interventional cardiology and peripheral vascular devices market is segmented into hospitals, ambulatory surgery centers, nursing facilities, clinics, and others.

Distribution Channel

  • Direct Tender
  • Third Party Distributors
  • Others

Asia-Pacific Interventional Cardiology

On the basis of distribution channel, the Asia-Pacific interventional cardiology and peripheral vascular devices market is segmented into direct tenders, third party distributors, and others.

 Interventional Cardiology and Peripheral Vascular Devices Market Regional Analysis/Insights

The interventional cardiology and peripheral vascular devices market is analysed and market size insights and trends are provided by country, product, type, procedure, indication, age group, end user, and distribution channel as referenced above.

The countries covered in the gastric cancer treatment market report are China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and rest of Asia-Pacific.

China dominates the interventional cardiology and peripheral vascular devices market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and well-developed healthcare infrastructure in this country.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Interventional Cardiology and Peripheral Vascular Devices Market Share Analysis

The interventional cardiology and peripheral vascular devices market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on interventional cardiology and peripheral vascular devices market.

Some of the major companies operating in the Asia-Pacific interventional cardiology and peripheral vascular devices market are Medtronic, BD., Cordis., Abbott., Boston Scientific Corporation, AngioDynamics., SMT, Edwards Lifesciences Corporation., Biosensors International Group, Ltd., W. L. Gore & Associates, Inc., Teleflex Incorporated., OrbusNeich Medical Company Limited, Merit Medical Systems., Terumo Medical Corporation, B. Braun Melsungen AG, MicroPort Scientific Corporation, Lepu Medical Technology(Beijing)Co. ,Ltd and Koninklijke Philips N.V. among others.

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global Vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.

  

SKU-

TABLE 1 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 2 ASIA-PACIFIC ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 3 ASIA-PACIFIC STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 4 ASIA-PACIFIC CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 5 ASIA-PACIFIC CATHETERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 6 ASIA-PACIFIC ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 7 ASIA-PACIFIC INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 8 ASIA-PACIFIC PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 9 ASIA-PACIFIC HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 10 ASIA-PACIFIC OTHER AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 11 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 12 ASIA-PACIFIC CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 13 ASIA-PACIFIC ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 14 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 15 ASIA-PACIFIC PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 16 ASIA-PACIFIC ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 17 ASIA-PACIFIC TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 18 ASIA-PACIFIC ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 19 ASIA-PACIFIC PERIPHERAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 20 ASIA-PACIFIC FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 21 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 22 ASIA-PACIFIC PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 23 ASIA-PACIFIC CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 24 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 25 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 26 ASIA-PACIFIC HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 27 ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 28 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 29 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 30 ASIA PACIFIC ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 31 ASIA PACIFIC STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 32 ASIA PACIFIC CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 33 ASIA PACIFIC CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 34 ASIA PACIFIC ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 35 ASIA PACIFIC INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 36 ASIA PACIFIC PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 37 ASIA PACIFIC HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 38 ASIA PACIFIC OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 39 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 40 ASIA PACIFIC CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 41 ASIA PACIFIC ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 42 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 43 ASIA PACIFIC ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 44 ASIA PACIFIC FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 45 ASIA PACIFIC TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 46 ASIA PACIFIC PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 47 ASIA PACIFIC ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 48 ASIA PACIFIC PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 49 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 50 ASIA PACIFIC PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 51 ASIA PACIFIC CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 52 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 53 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 54 ASIA PACIFIC HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 55 ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 56 CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 57 CHINA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 58 CHINA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 59 CHINA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 60 CHINA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 61 CHINA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 62 CHINA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 63 CHINA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 64 CHINA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 65 CHINA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 66 CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 67 CHINA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 68 CHINA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 69 CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 70 CHINA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 71 CHINA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 72 CHINA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 73 CHINA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 74 CHINA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 75 CHINA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 76 CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 77 CHINA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 78 CHINA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 79 CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 80 CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 81 CHINA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 82 CHINA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 83 INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 84 INDIA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 85 INDIA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 86 INDIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 87 INDIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 88 INDIA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 89 INDIA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 90 INDIA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 91 INDIA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 92 INDIA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 93 INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 94 INDIA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 95 INDIA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 96 INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 97 INDIA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 98 INDIA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 99 INDIA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 100 INDIA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 101 INDIA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 102 INDIA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 103 INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 104 INDIA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 105 INDIA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 106 INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 107 INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 108 INDIA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 109 INDIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 110 JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 111 JAPAN ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 112 JAPAN STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 113 JAPAN CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 114 JAPAN CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 115 JAPAN ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 116 JAPAN INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 117 JAPAN PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 118 JAPAN HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 119 JAPAN OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 120 JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 121 JAPAN CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 122 JAPAN ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 123 JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 124 JAPAN ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 125 JAPAN FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 126 JAPAN TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 127 JAPAN PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 128 JAPAN ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 129 JAPAN PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 130 JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 131 JAPAN PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 132 JAPAN CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 133 JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 134 JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 135 JAPAN HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 136 JAPAN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 137 SOUTH KOREA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 138 SOUTH KOREA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 139 SOUTH KOREA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 140 SOUTH KOREA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 141 SOUTH KOREA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 142 SOUTH KOREA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 143 SOUTH KOREA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 144 SOUTH KOREA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 145 SOUTH KOREA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 146 SOUTH KOREA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 147 SOUTH KOREA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 148 SOUTH KOREA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 149 SOUTH KOREA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 150 SOUTH KOREA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 151 SOUTH KOREA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 152 SOUTH KOREA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 153 SOUTH KOREA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 154 SOUTH KOREA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 155 SOUTH KOREA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 156 SOUTH KOREA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 157 SOUTH KOREA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 158 SOUTH KOREA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 159 SOUTH KOREA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 160 SOUTH KOREA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 161 SOUTH KOREA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 162 SOUTH KOREA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 163 SOUTH KOREA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 164 AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 165 AUSTRALIA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 166 AUSTRALIA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 167 AUSTRALIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 168 AUSTRALIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 169 AUSTRALIA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 170 AUSTRALIA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 171 AUSTRALIA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 172 AUSTRALIA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 173 AUSTRALIA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 174 AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 175 AUSTRALIA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 176 AUSTRALIA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 177 AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 178 AUSTRALIA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 179 AUSTRALIA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 180 AUSTRALIA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 181 AUSTRALIA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 182 AUSTRALIA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 183 AUSTRALIA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 184 AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 185 AUSTRALIA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 186 AUSTRALIA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 187 AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 188 AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 189 AUSTRALIA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 190 AUSTRALIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 191 SINGAPORE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 192 SINGAPORE ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 193 SINGAPORE STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 194 SINGAPORE CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 195 SINGAPORE CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 196 SINGAPORE ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 197 SINGAPORE INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 198 SINGAPORE PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 199 SINGAPORE HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 200 SINGAPORE OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 201 SINGAPORE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 202 SINGAPORE CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 203 SINGAPORE ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 204 SINGAPORE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 205 SINGAPORE ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 206 SINGAPORE FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 207 SINGAPORE TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 208 SINGAPORE PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 209 SINGAPORE ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 210 SINGAPORE PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 211 SINGAPORE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 212 SINGAPORE PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 213 SINGAPORE CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 214 SINGAPORE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 215 SINGAPORE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 216 SINGAPORE HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 217 SINGAPORE INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 218 THAILAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 219 THAILAND ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 220 THAILAND STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 221 THAILAND CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 222 THAILAND CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 223 THAILAND ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 224 THAILAND INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 225 THAILAND PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 226 THAILAND HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 227 THAILAND OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 228 THAILAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 229 THAILAND CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 230 THAILAND ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 231 THAILAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 232 THAILAND ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 233 THAILAND FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 234 THAILAND TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 235 THAILAND PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 236 THAILAND ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 237 THAILAND PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 238 THAILAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 239 THAILAND PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 240 THAILAND CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 241 THAILAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 242 THAILAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 243 THAILAND HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 244 THAILAND INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 245 MALAYSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 246 MALAYSIA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 247 MALAYSIA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 248 MALAYSIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 249 MALAYSIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 250 MALAYSIA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 251 MALAYSIA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 252 MALAYSIA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 253 MALAYSIA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 254 MALAYSIA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 255 MALAYSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 256 MALAYSIA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 257 MALAYSIA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 258 MALAYSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 259 MALAYSIA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 260 MALAYSIA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 261 MALAYSIA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 262 MALAYSIA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 263 MALAYSIA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 264 MALAYSIA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 265 MALAYSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 266 MALAYSIA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 267 MALAYSIA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 268 MALAYSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 269 MALAYSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 270 MALAYSIA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 271 MALAYSIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 272 INDONESIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 273 INDONESIA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 274 INDONESIA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 275 INDONESIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 276 INDONESIA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 277 INDONESIA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 278 INDONESIA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 279 INDONESIA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 280 INDONESIA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 281 INDONESIA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 282 INDONESIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 283 INDONESIA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 284 INDONESIA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 285 INDONESIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 286 INDONESIA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 287 INDONESIA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 288 INDONESIA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 289 INDONESIA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 290 INDONESIA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 291 INDONESIA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 292 INDONESIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 293 INDONESIA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 294 INDONESIA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 295 INDONESIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 296 INDONESIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 297 INDONESIA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 298 INDONESIA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 299 PHILIPPINES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 300 PHILIPPINES ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 301 PHILIPPINES STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 302 PHILIPPINES CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 303 PHILIPPINES CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 304 PHILIPPINES ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 305 PHILIPPINES INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 306 PHILIPPINES PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 307 PHILIPPINES HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 308 PHILIPPINES OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 309 PHILIPPINES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 310 PHILIPPINES CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 311 PHILIPPINES ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 312 PHILIPPINES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 313 PHILIPPINES ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 314 PHILIPPINES FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 315 PHILIPPINES TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 316 PHILIPPINES PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 317 PHILIPPINES ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 318 PHILIPPINES PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)

TABLE 319 PHILIPPINES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 320 PHILIPPINES PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 321 PHILIPPINES CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 322 PHILIPPINES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 323 PHILIPPINES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 324 PHILIPPINES HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 325 PHILIPPINES INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 326 REST OF ASIA PACIFIC INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market is growing with a CAGR of 8.4% during the forecast period of 2022 to 2029
The significant factors flourishing the growth of Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market are The Rise in Prevalence of Chronic Diseases, such as Coronary Artery Disease, Ischemic Heart Disease and Vascular Diseases and Awareness Among the Population about the Treatment and Use of the Devices.
The Asia-Pacific interventional cardiology and peripheral vascular devices market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market.
The major players operating in the Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market are Medtronic, BD., Cordis., Abbott., Boston Scientific Corporation, AngioDynamics., SMT, Edwards Lifesciences Corporation., Biosensors International Group, Ltd., W. L. Gore & Associates, Inc., Teleflex Incorporated., OrbusNeich Medical Company Limited, Merit Medical Systems., Terumo Medical Corporation, B. Braun Melsungen AG, MicroPort Scientific Corporation, Lepu Medical Technology(Beijing)Co.,Ltd and Koninklijke Philips N.V.

BROWSE RELATED REPORTS

Global Interventional Cardiology and Peripheral Vascular Devices Market – Industry Trends and Forecast to 2029
North America Interventional Cardiology and Peripheral Vascular Devices Market – Industry Trends and Forecast to 2029
Europe Interventional Cardiology and Peripheral Vascular Devices Market – Industry Trends and Forecast to 2029
Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market – Industry Trends and Forecast to 2030

BROWSE RELATED Blogs

Advancements in Interventional Cardiology and Vascular Devices

BROWSE RELATED Press Release

Rising Geriatric Population Base All around the Globe is one of the Major Factors Fostering the Growth of the Interventional Cardiology and Peripheral Vascular Devices Market
Boston Scientific Corporation, Abbott, and Terumo Corporation is Expected to Dominate the Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market in 2021
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Can be used by entire organization across the globe + Downloadable and Printable PDF + 30 + Countries

Buy Now
Request for TOC Speak to Analyst Inquire Before Buying Free Sample Report
Advance Formative Research Customization Request for bulk Reports

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials

David Manning - Thermo Fisher Scientific
Director, Global Strategic Accounts,

Dear Ricky,
I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.

Image
Manager - Market Analytics,
Uriah D. Avila - Zeus Polymer Solutions

Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.

Business Development Manager,
(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.

Image
Business Intelligence and Analytics,
Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst,
Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director,
Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO,
A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director,
Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager,
Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations,
GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst,
Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager,
Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment
MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer
Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro
Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department)
UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future